NASDAQ:APTO - Aptose Biosciences Inc.
$1.83
 $-0.02
-1.08%
4:00PM EDT
2019-04-18
Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities. The Company develops therapeutics focused on epigenetic processes and signal transduction abnormalities at the edge of cancer research, coupled with companion diagnostics to identify the optimal patient population for its products. The Company's APTO-253 is a small molecule that can induce expression of the genes that codes for the Kruppel-like factor 4 (KLF4) master transcription factor and the p21 cell cycle inhibitor protein. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  APTO     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 64   203. 85   241. 91  
42 stocks rank:  3. 67 K 1. 44 K 1. 05 K
# analyst opinions:  1. 00   14. 51   13. 97  
mean recommendation:  2. 00   2. 09   2. 01  

quick ratio:  5. 64   5. 27   1. 81  
current ratio:  5. 91   5. 62   2. 25  

target price low:  4. 89   84. 80   115. 21  
target price avg:  4. 89   111. 51   137. 51  
target price high:  4. 89   135. 81   157. 84  
1-yr high:  4. 50   114. 23   138. 78  
last close:  1. 83   87. 66   116. 69  
50-day avg:  1. 92   95. 54   123. 44  
200-day avg:  2. 36   94. 25   121. 11  
1-yr low:  1. 61   72. 78   98. 34  
volume:  103. 23 K 4. 11 M 8. 07 M
50-day avg volume:  307. 73 K 2. 76 M 5. 02 M
200-day avg volume:  241. 37 K 2. 92 M 4. 59 M

1-day return:  -1. 08 % -0. 41 % 0. 07 %
this week return:  -3. 17 % -5. 74 % -4. 11 %
12-wk return:  -11. 59 % 1. 61 % -0. 05 %
52-wk return:  -43. 94 % 3. 12 % 8. 78 %

enterprise value (EV):  60. 20 M 48. 94 B 114. 64 B
market cap:  73. 69 M 43. 07 B 104. 73 B
EBITDA:  -24. 02 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -2. 51   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -28. 87 M 2. 20 B 4. 20 B

shares outstanding:  37. 78 M 571. 70 M 1. 24 B
shares:  36. 20 M 571. 81 M 1. 23 B
shares short:  404. 83 K 10. 17 M 13. 00 M
shares short prior month:  491. 89 K 9. 54 M 17. 33 M
short ratio:  0. 95   5. 41   3. 28  
short % of float:  0. 99 % 5. 45 % 2. 38 %
total cash/share:  0. 38   11. 14   9. 33  
total cash:  15. 74 M 6. 71 B 7. 15 B
free cash flow:  -10. 36 M 3. 58 B 2. 96 B
operating cash flow:  -23. 21 M 4. 15 B 4. 30 B

book value:  0. 37   12. 78   26. 92  
price/book:  4. 96   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  17. 97 % --- ---
1-yr mean volatility:  -0. 16 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 86   2. 40   4. 10  
forward EPS:  -0. 54   3. 97   7. 13  
P/E:  -2. 12   13. 63   22. 72  
forward P/E:  -2. 61   -15. 95   13. 99  
PE/G:  0. 07   -1. 65   -1. 32  
growth:  -29. 82 % 127. 12 % 29. 61 %
earnings high:  -0. 12   1. 00   1. 66  
earnings avg:  -0. 15   0. 77   1. 53  
earnings low:  -0. 20   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -104. 50 % -2. 75 % 4. 55 %
return on equity:  -237. 76 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  1. 24   1. 25   0. 93  
sharpe (1yr):  -0. 62   0. 37   0. 70  


Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : APTO
.    + 0.488 =         0.488 :: INITIAL WEIGHT
.   + 47.917 =        48.404 :: spline projection addition
.    x 1.431 =        69.287 :: industry recommendation factor
.    x 2.068 =       143.317 :: symbol recommendation factor
.     x 0.99 =        141.82 :: return on assets factor
.    x 0.976 =       138.448 :: return on equity factor
.    x 2.949 =       408.284 :: current ratio factor
.    x 1.102 =       450.109 :: quick ratio factor
.    x 1.441 =       648.446 :: short ratio factor
.     x 2.05 =      1329.051 :: price-to-book factor
.    x 2.141 =      2845.349 :: P/E weight
.    x 1.938 =      5513.329 :: PE/G factor
.     x 1.48 =      8158.342 :: beta factor
.    x 0.621 =      5067.509 :: sharpe factor
.    x 2.505 =     12695.052 :: target low factor
.    x 1.431 =     18167.081 :: target mean factor
.    x 1.129 =     20516.283 :: target high factor
.     x 1.31 =     26874.031 :: industry 2-weeks return factor
.    x 0.992 =     26660.817 :: overall "drift" factor
.     x 0.82 =     21869.244 :: largest single-day jump factor
.    x 0.065 =      1424.706 :: low price factor
.      x 1.0 =      1424.475 :: factor hist industry gain for week 16
.   cubeRoot =        11.252 :: reduced to standardize
.   - 22.858 =         0.645 :: add/subtract for performance
.                      0.645 :: FINAL WEIGHT for NASDAQ:APTO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org